Abstract:The aim of this study was to assess in vitro meiosis resumption and nuclear maturation of Rattus norvegicus oocytes after vitrification with different cryoprotective solutions. Cumulus-oocyte complexes (COCs) were exposed to an equilibration solution for 4 min placed in cryoprotective solutions for 1 min and vitrified in open pulled straws. Cryoprotective solutions were prepared with 15% ethylene glycol + 15% dimethyl sulfoxide + 0.5 M sucrose and different supplements, to form the following groups: G1, 20% fe… Show more
“… Parisa Jamalzaei [ 222 ] 2020 A HAA composed of HA and ALG Mouse preantral follicles Promoted the development of preantral follicles and oocyte maturation in mice and enhanced estrogen secretion. L M G Paim [ 224 ] 2015 A vitrification solution with 1% hyaluronic acid The cumulus oocyte complex Improved the meiotic recovery rate and nuclear maturation rate of norvegicus oocytes. Somayeh Tavana [ 225 ] 2016 The HABH Ovariectomized rats Prevented or reduced early ischemia-induced follicular loss, promoted follicular survival and angiogenesis.…”
Section: Biomaterials For Ovarian Aging Therapymentioning
confidence: 99%
“…Vitrification of embryos has been successful, while cryopreservation of oocytes has still failed to achieve the expected results [ 223 ]. Paim et al used a vitrification solution with 1% hyaluronic acid to freeze the cumulus oocyte complex (COC) for 7 days and then heated and matured it in vitro for 30 h [ 224 ]. The results showed that adding 1% hyaluronic acid to vitrified frozen solution could improve the meiotic recovery rate and nuclear maturation rate of Rattus norvegicus oocytes in vitro.…”
Section: Biomaterials For Ovarian Aging Therapymentioning
Ovarian aging is characterized by a progressive decline in ovarian function. With the increase in life expectancy worldwide, ovarian aging has gradually become a key health problem among women. Over the years, various strategies have been developed to preserve fertility in women, while there are currently no clinical treatments to delay ovarian aging. Recently, advances in biomaterials and technologies, such as three-dimensional (3D) printing and microfluidics for the encapsulation of follicles and nanoparticles as delivery systems for drugs, have shown potential to be translational strategies for ovarian aging. This review introduces the research progress on the mechanisms underlying ovarian aging, and summarizes the current state of biomaterials in the evaluation and treatment of ovarian aging, including safety, potential applications, future directions and difficulties in translation.
Graphical Abstract
“… Parisa Jamalzaei [ 222 ] 2020 A HAA composed of HA and ALG Mouse preantral follicles Promoted the development of preantral follicles and oocyte maturation in mice and enhanced estrogen secretion. L M G Paim [ 224 ] 2015 A vitrification solution with 1% hyaluronic acid The cumulus oocyte complex Improved the meiotic recovery rate and nuclear maturation rate of norvegicus oocytes. Somayeh Tavana [ 225 ] 2016 The HABH Ovariectomized rats Prevented or reduced early ischemia-induced follicular loss, promoted follicular survival and angiogenesis.…”
Section: Biomaterials For Ovarian Aging Therapymentioning
confidence: 99%
“…Vitrification of embryos has been successful, while cryopreservation of oocytes has still failed to achieve the expected results [ 223 ]. Paim et al used a vitrification solution with 1% hyaluronic acid to freeze the cumulus oocyte complex (COC) for 7 days and then heated and matured it in vitro for 30 h [ 224 ]. The results showed that adding 1% hyaluronic acid to vitrified frozen solution could improve the meiotic recovery rate and nuclear maturation rate of Rattus norvegicus oocytes in vitro.…”
Section: Biomaterials For Ovarian Aging Therapymentioning
Ovarian aging is characterized by a progressive decline in ovarian function. With the increase in life expectancy worldwide, ovarian aging has gradually become a key health problem among women. Over the years, various strategies have been developed to preserve fertility in women, while there are currently no clinical treatments to delay ovarian aging. Recently, advances in biomaterials and technologies, such as three-dimensional (3D) printing and microfluidics for the encapsulation of follicles and nanoparticles as delivery systems for drugs, have shown potential to be translational strategies for ovarian aging. This review introduces the research progress on the mechanisms underlying ovarian aging, and summarizes the current state of biomaterials in the evaluation and treatment of ovarian aging, including safety, potential applications, future directions and difficulties in translation.
Graphical Abstract
C-type natriuretic peptide (CNP) has been considered as a physiological meiotic inhibitor that stimulates the cGMP production by cumulus cell natriuretic peptide receptor 2 (NPR2), which inhibits oocyte phosphodiesterase type 3 activity and increases cAMP. In this study, we explored the effect of CNP pretreatment on the in vitro maturation (IVM) of bovine oocytes by examining changes in cleavage rate, blastocyst formation, mitochondrial DNA (mtDNA) copy number, reactive oxygen species (ROS) level, glutathione (GSH) content, and redox state. Our results showed that 200 nM CNP could effectively maintain meiotic arrest of bovine oocytes in vitro within 6 h. The two-step IVM system in which oocytes were pretreated with 200 nM CNP for 6 h and then cultured IVM for 28 h yielded a significantly (P < 0.05) increased blastocyst rate and cell number after in vitro fertilization (IVF) while compared to the conventional one-step IVM method. In addition, in comparison with the conventional 24-h matured oocyte, oocytes pretreated with 200 nM CNP for 6 h followed by 28 h IVM resulted in significantly (P < 0.05) higher mtDNA copy number and ROS levels in oocytes, while GSH level significantly (P < 0.05) decreased. Remarkably, regardless of treatment, no changes were observed in FAD++, NAD(P)H autofluorescence intensity, and redox ratio (FAD++/NAD(P)H) within the oocytes, maintaining a healthy metabolic equilibrium of redox throughout the two-step IVM. In conclusion, these results indicate that CNP pretreatment could dramatically improve the quality of bovine oocytes during in vitro maturation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.